funder-graph

FundersCATorrey Coast Foundation › 2024

Grants paid by Torrey Coast Foundation, tax year 2024

EIN 85-4224393 · San Diego, CA · Form 990-PF, Part XV · NTEE T22

In tax year 2024, Torrey Coast Foundation (EIN 85-4224393) reported 25 grants paid totaling $10,685,429. Dataset version 2026.09.0, built 2026-09-03.

2021202220232024

Every grant, 2024

Grants reported by Torrey Coast Foundation for tax year 2024
Tax yearRecipientMatchAmountTypePurposeSource filing
2024The Entertainment Industry Foundation ( Stand Up for Cancer) Los Angeles, CAD$2,550,000paidSCIENTIFIC RESEARCH202503219349100750
2024Su2c Convergence - Project 2 Los Angeles, CAU$1,150,000paidSCIENTIFIC RESEARCH202503219349100750
2024Mark Foundation for Cancer Research (mfcr) New York, NYC$1,000,000paidMEDICAL RESEARCH202503219349100750
2024University of California San Diego (uc San Diego) La Jolla, CAU$1,000,000approved, futureSCIENTIFIC RESEARCH202503219349100750
2024Su2c Amendment #3 - Project 3 Los Angeles, CAU$690,000approved, futureMEDICAL RESEARCH202503219349100750
2024Su2c Amendment #3 - Project 3 Los Angeles, CAU$690,000paidMEDICAL RESEARCH202503219349100750
2024Ucsd Foundation La Jolla, CAU$535,000paidMEDICAL RESEARCH202503219349100750
2024Memorial Sloan Kettering Cancer Center New York, NYU$500,000paidMEDICAL RESEARCH202503219349100750
2024Su2c Amendment #4 Los Angeles, CAU$500,000approved, futureMEDICAL RESEARCH202503219349100750
2024Columbia University New York, NYC$500,000paidSCIENTIFIC RESEARCH202503219349100750
2024La Jolla Country Day La Jolla, CAC$500,000paidGENERAL FUNDING202503219349100750
2024Medical College Cornell New York, NYU$302,500paidMEDICAL RESEARCH202503219349100750
2024Lyell Immunopharma (fka Immpact Bio USA Inc) West Hills, CAU$259,122paidSCIENTIFIC RESEARCH202503219349100750
2024The University of Texas Md Anderson Cancer Center Houston, TXU$250,000paidSCIENTIFIC RESEARCH202503219349100750
2024Mark Foundation for Cancer Research (mfcr) New York, NYC$250,000paidMEDICAL RESEARCH202503219349100750
2024Dana-Farber Cancer Institute Inc Boston, MAB$249,731paidMEDICAL RESEARCH202503219349100750
2024University of Pennsylvania Philadelphia, PAU$247,500paidSCIENTIFIC RESEARCH202503219349100750
2024Icahn School of Medicine at Mount Sinai New York, NYB$234,576paidSCIENTIFIC RESEARCH202503219349100750
2024Stanford Stanford, CAC$200,000paidSCIENTIFIC RESEARCH202503219349100750
2024Gateway Cancer Research Schaumburg, ILD$200,000paidSCIENTIFIC RESEARCH202503219349100750
2024La Jolla Institute for Immunology Gemini La Jolla, CAC$175,000paidGENERAL FUNDING202503219349100750
2024Whitehead Institute Cambridge, MAU$160,000paidMEDICAL RESEARCH202503219349100750
2024Broad Institute Cambridge, MAB$157,000paidSCIENTIFIC RESEARCH202503219349100750
2024Columbia University New York, NYC$150,000paidMEDICAL RESEARCH202503219349100750
2024Stanford University Stanford, CAC$150,000paidSCIENTIFIC RESEARCH202503219349100750
2024Cancer Research Institute New York, NYB$100,000paidMEDICAL RESEARCH202503219349100750
2024Scripps Health Foundation San Diego, CAC$100,000paidMEDICAL RESEARCH202503219349100750
2024National Association San Diego Foundation San Diego, CAD$75,000paidSCIENTIFIC RESEARCH202503219349100750

Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.

Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.

Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.

The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.

This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.